Go offline with the Player FM app!
JACC Asia - Efficacy and Safety of Sacubitril/Allisartan for the Treatment of Primary Hypertension
Manage episode 437963178 series 1136185
In this episode of the JACC: Asia podcast, Dr. Magnus O. Wijkman reviews a pivotal study comparing the angiotensin receptor neprilysin inhibitor sacubitril alisarmin with olmesartan for treating primary hypertension in Chinese patients. The trial found sacubitril alisarmin to be more effective in reducing blood pressure and well-tolerated, suggesting its potential as a new option for hypertension treatment, though further long-term studies are needed.
1270 episodes
Manage episode 437963178 series 1136185
In this episode of the JACC: Asia podcast, Dr. Magnus O. Wijkman reviews a pivotal study comparing the angiotensin receptor neprilysin inhibitor sacubitril alisarmin with olmesartan for treating primary hypertension in Chinese patients. The trial found sacubitril alisarmin to be more effective in reducing blood pressure and well-tolerated, suggesting its potential as a new option for hypertension treatment, though further long-term studies are needed.
1270 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.